Viewing Study NCT05105191



Ignite Creation Date: 2024-05-06 @ 4:50 PM
Last Modification Date: 2024-10-26 @ 2:17 PM
Study NCT ID: NCT05105191
Status: TERMINATED
Last Update Posted: 2021-11-03
First Post: 2021-09-29

Brief Title: Analytical Performances and Clinical Impact of the Roche Cobas Liat Influenza AB RSV Assay in the Management of Adult and Pediatric Patients Attending the Emergency Room
Sponsor: Erasme University Hospital
Organization: Erasme University Hospital

Study Overview

Official Title: Analytical Performances and Clinical Impact of the Roche Cobas Liat Influenza AB RSV Assay in the Management of Adult and Pediatric Patients Attending the Emergency Room
Status: TERMINATED
Status Verified Date: 2021-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: COVID-19 pandemic introduced a confusion bias
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Molecular techniques for respiratory virus detection have already shown benefits in terms of sensitivity gained in comparison to conventional techniques Recent progress has made it possible to shorten turnaround time TAT and to allow delivery of results in a timely manner especially in comparison to cell culture and direct fluorescence assays DFA However the cost of these molecular assays is usually not taken in charge by public health insurance system This could be partly explained by the fact that molecular techniques have not clearly shown cost-effectiveness Results of molecular tests for influenza viruses and RSV if delivered rapidly in the emergency room ER would most likely help avoid antibiotic use and ancillary test prescription improve antiviral prescription and shorten length of stay in the ward by facilitating discharge or cohorting of hospitalized patients The goal of this study is to assess the performances of Roche Cobas Liat Influenza AB RSV assay to appraise its clinical impact and to evaluate its cost effectiveness
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: True
Is an FDA AA801 Violation?: None